Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lower Extremity Arterial Disease”

416 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 416 results

Early research (Phase 1)Study completedNCT01859117
What this trial is testing

Study of PDA-002 in Subjects With Peripheral Arterial Disease and Diabetic Foot Ulcers

Who this might be right for
Peripheral Arterial DiseaseDiabetic Foot Ulcer
Celularity Incorporated 15
Not applicableNot Yet RecruitingNCT06835660
What this trial is testing

DRug-Eluting BallOOn Versus Primary Polymer-coated Paclitaxel Eluting STenting for Femoro-popliteal Lesions

Who this might be right for
Femoropopliteal Lesion
Assistance Publique - Hôpitaux de Paris 402
Not applicableStudy completedNCT02247661
What this trial is testing

Hip Abductor Strengths, Limping and Trochanteric Tenderness After Hip Arthroplasty Due to Femoral Neck Fracture

Who this might be right for
Femoral Neck FractureTrochanteric Pain
Sundsvall Hospital 48
Not applicableUnknownNCT02813161
What this trial is testing

The Diabetic Foot Ulcer Registry

Who this might be right for
Diabetic Foot Ulcer OutcomeQuality of Patient Care
U.S. Wound Registry 10,000
Not applicableEnded earlyNCT01599442
What this trial is testing

Register for Patients With Diabetic Foot Syndrome and Critical Limb Ischemia

Who this might be right for
Type 2 Diabetes MellitusDiabetic FootCritical Limb Ischemia
GWT-TUD GmbH 123
Not applicableStudy completedNCT01742455
What this trial is testing

Assessment of Natural Bypasses in the Lower Limb

Who this might be right for
Peripheral CollateralsArteriogenesisCoronary Artery Disease
Insel Gruppe AG, University Hospital Bern 30
Not applicableStudy completedNCT04257370
What this trial is testing

Kerecis Omega3 Wound Plus SOC vs. SOC Alone in Treating Severe Diabetic Foot Ulcers and Forefoot Amputations

Who this might be right for
Diabetic Foot UlcerDehiscence of Amputation StumpAmputation
Kerecis Ltd. 260
Large-scale testing (Phase 3)Looking for participantsNCT05132439
What this trial is testing

MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

Who this might be right for
Intermittent Claudication
VA Office of Research and Development 200
Not applicableStudy completedNCT01292928
What this trial is testing

SuperNOVA Clinical Stenting Trial

Who this might be right for
Atherosclerosis of Native Arteries of the Extremities, Unspecified
Boston Scientific Corporation 299
Not applicableUnknownNCT02866656
What this trial is testing

The Clinical Research of Low Intensity Continuous Ultrasonic on Lower Limb Arteriosclerosis Occlusion（ASO） Syndrome

Who this might be right for
Arteriosclerosis
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 90
Not applicableLooking for participantsNCT06976073
What this trial is testing

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Who this might be right for
Diabetes Mellitus, Type 2Diabetic FootPeripheral Arterial Disease+2 more
HJN Sverige AB/Neko Health 8,000
Not applicableWithdrawnNCT06387355
What this trial is testing

Diagnosis and Treatment of CAD in Severe PAD After Lower Extremity Revascularization

Who this might be right for
Peripheral Artery DiseaseCoronary Artery Disease
VA Office of Research and Development
Not applicableUnknownNCT02832024
What this trial is testing

Clinical Study of Stent Versus Direct Atherectomy Versus Angioplasty to Treat Lower Limb In-stent Restenosis

Who this might be right for
AtherosclerosisIn-stent Arterial Restenosis
Xuanwu Hospital, Beijing 120
Large-scale testing (Phase 3)Study completedNCT00693940
What this trial is testing

Effectiveness of Group Walking Sessions for Increasing Activity in People With Peripheral Arterial Disease (The Group Oriented Arterial Leg Study [GOALS])

Who this might be right for
Peripheral Vascular DiseasesCardiovascular Diseases
Northwestern University 194
Not applicableActive Not RecruitingNCT06636968
What this trial is testing

A Real-world Study to Evaluate the Effectiveness of Intravascular Lithotripsy in Moderate to Severe Calcification Lesion of Lower Extremity Femoropopliteal Artery

Who this might be right for
Peripheral Arterial Disease
Shanghai Zhongshan Hospital 200
Testing effectiveness (Phase 2)Study completedNCT03194776
What this trial is testing

Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication

Who this might be right for
Peripheral Artery Disease (PAD); Intermittent Claudication
Novartis Pharmaceuticals 46
Testing effectiveness (Phase 2)Study completedNCT00537498
What this trial is testing

Urokinase Therapy in Diabetic Foot Syndrome

Who this might be right for
Diabetic FootArterial Occlusive DiseaseIschemia
medac GmbH 77
Not applicableLooking for participantsNCT06989216
What this trial is testing

Multi-modal Quantitative Imaging of the Skin

Who this might be right for
Skin CancerSkin DiseasesAtopic Dermatitis+4 more
HJN Sverige AB/Neko Health 8,000
Not applicableStudy completedNCT07312513
What this trial is testing

Multicenter, Randomized, Non-inferiority Study to Compare the Performance and Safety of Debrisoft® Duo With Debrisoft® Pad in the Debridement of Wounds

Who this might be right for
Diabetic UlcersArterial UlcersVenous Ulcers+6 more
Lohmann & Rauscher 100
Large-scale testing (Phase 3)Ended earlyNCT00338585
What this trial is testing

Study of Alfimeprase's Ability to Dissolve Blood Clots in the Leg and Help Prevent the Need for Surgery

Who this might be right for
Arterial Occlusive Diseases
ARCA Biopharma, Inc. 300
Next Page